Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Guiding decisions

How the ever-changing face of market research continues to impact the healthcare industry

Sexual selection

What happens in the interview room accelerates industry evolution

- PMLiVE

BMS appoints Peter Arduini to board of directors

He brings experience from Integra LifeSciences and Baxter Healthcare

- PMLiVE

Dr Niall Murphy and Pierre Schwich join Pharnext

They take up the roles of chief scientific officer and chief financial officer

Roche - Basel

Roche boosts cancer portfolio with $1bn Blueprint deal

Collaboration will focus on the development of its ‘immunokinases’ immuno-oncology treatment

- PMLiVE

Valeant shares slide on fears of filing default

Cuts revenue forecasts for 2016 following report of fourth-quarter loss

- PMLiVE

Social media and inflation penalties for generic drugs

US generic drug companies are under more scrutiny as the US public becomes more vocal 

- PMLiVE

Sally Waterman appointed as chair of OBN

She succeeds David Laskow-Pooley

- PMLiVE

Mary Briggs moves from Covance to eClinicalHealth

Becomes head of business development and North American operations

- PMLiVE

Pharma needs to ‘better articulate’ its value to society

And that includes its need to finance new medical discoveries by making a profit

- PMLiVE

FDA allows accelerated review for rivals to over-priced drugs

Aims to combat growing trend in exploitation of sole-source drug pricing

- PMLiVE

GW ascendant as epilepsy drug clears phase III trial

Epidiolex proves effective in controlling seizures in children with Dravet syndrome

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links